A Phase 1 Study of SH1573 Capsules in Subjects With Refractory or Relapsed Acute Myelogenous Leukemia

Clinical trial NCT04806659 · UNKNOWN

Trial details

NCT number: NCT04806659
Sponsor: Nanjing Sanhome Pharmaceutical, Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2020-08-04
Primary completion: 2023-08-31
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.